Pharmacy Times recap of the current status of the test to treat initiative, featuring OmniSYS CIO David Pope, PharmD, CDE. Despite AMA pushback, pharmacy is ready for test and treat.
The Drug Topics editorial board, including OmniSYS CIO David Pope, PharmD, CDE responds to the AMA’s recent negative statement regarding the test to treat initiative outlined by the Biden Administration.
Pharmacy Times interview with OmniSYS CIO David Pope and Christina Madison, The Public Health Pharmacist, discussing the new test to treat plan mentioned in the 2022 State of the Union.
Test to treat in pharmacy: Drug Topics asked OmniSYS chief innovation officer David Pope for his thoughts regarding test to treat after President Biden’s 2022 State of the Union address.
Clinical pharmacy is in demand and sustainable pharmacy technology makes it happen. Pharmacies must make the most of current technology investments, and building upon them for an automated, efficient future.
XIFIN’s acquisition of OmniSYS is the latest evidence that pharmacies are the front door to healthcare. Uniting lab data with pharmacy data is a game-changer, for now and the future.
Great news! We’ve enhanced our Medicare Part D Comparison Tool to better support your pharmacy during open enrollment, included free of charge with our clinical services and patient communications solutions.
To combat the growing diabetes epidemic, OmniSYS is partnering with the CDC, NSPA and ADCES and 30 community pharmacies, focusing on delaying or preventing type 2 diabetes through preventative encounters.
DSN sat down with OmniSYS CEO John King to discuss the challenges COVID-19 brought tor the pharmacy industry and how OmniSYS has been able to assist pharmacists with said challenges.
The Drug Store News March 2021 cover story takes a deep dive into the essential role pharmacies are playing in COVD-19 vaccinations, with insights from key players across the industry.
Virtustream announced today that OmniSYS is utilizing the Virtustream Enterprise Cloud and xStreamCare Services™ to ensure its software solutions can meet the surging demand due to the COVID-19 vaccination push.
OmniSYS prides itself on its modular solutions. And now we have our newest innovation: Encounter-Rx™. Cloud-based and inherently sophisticated, Encounter-Rx take technological integration and workflow efficiency to the next level.
Copyright 2022 Omnisys, LLC. All rights reserved.
